Science Explorer Interactive view Map

Five Prime Therapeutics (United States)

Research works
91
▼ 25% vs 2013–17
Citations
2.6k
29.0 per fractional work
Top-10% rate
36.6%
record average 16.5%
Open access
50%
world 28%

Not ranked overall: Five Prime Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.84× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.44× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 5.80× its world share, 1 worksImmunology and Micro…Neuroscience: 0.82× its world share, 0 worksNeuroscienceComputer Science: 0.55× its world share, 0 worksComputer ScienceEngineering: 0.18× its world share, 0 worksEngineeringHealth Professions: 0.50× its world share, 0 worksHealth ProfessionsMedicine: 2.64× its world share, 6 worksMedicineBusiness, Management and Accounting: 0.41× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 8.91× its world share, 2 worksEconomics, Econometr…Psychology: 1.31× its world share, 0 worksPsychologySocial Sciences: 0.24× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Economics, Econometrics and Finance, 8.9×. Every wedge is a field page.

Who are the top researchers at Five Prime Therapeutics (United States)?

Ranked on the composite score, Robert Sikorski and Thomas J. Brennan lead among researchers whose main affiliation is Five Prime Therapeutics (United States).

  1. 1 Robert Sikorski United States · #227,530 worldwide 440 citations · 16 works
  2. 2 Thomas J. Brennan United States · #328,345 worldwide 131 citations · 20 works
All ranked researchers at Five Prime Therapeutics (United States)

Which keywords describe research at Five Prime Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Metabolism, Obesity, Tumor Microenvironment, Immunity, Therapy, Signaling and Inflammation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer12▲ 9.2×13 topics
  2. Metabolism9▲ 16×7 topics
  3. Inflammation7▲ 3.4×16 topics
  4. Obesity6▲ 9.2×6 topics
  5. Immunity6▲ 20×4 topics
  6. Tumor Microenvironment6▲ 19×5 topics
  7. Therapy5▲ 26×2 topics
  8. Signaling5▲ 49×2 topics
  9. FGF215▲ 345×1 topic
  10. Fibroblast Growth Factor5▲ 345×1 topic
  11. Immune Checkpoint Blockade5▲ 92×1 topic
  12. PD-1 and PD-L15▲ 92×1 topic
  13. Cancer Immunotherapy4▲ 35×3 topics
  14. Chronic Disease Management4▲ 29×4 topics
  15. Health Outcomes4▲ 18×2 topics
  16. Medication Adherence4▲ 71×2 topics
  17. Immunotherapy4▲ 5.9×9 topics
  18. Innate Immunity3▲ 11×6 topics
  19. Macrophage3▲ 66×2 topics
  20. Patient Compliance3▲ 180×1 topic
  21. Treatment Adherence3▲ 180×1 topic
  22. Activation3▲ 104×1 topic
  23. Glycosylation3▲ 16×3 topics
  24. Polarization3▲ 40×1 topic
  25. Pharmaceutical Industry3▲ 87×2 topics
  26. Antigen Presentation3▲ 34×2 topics
  27. Monoclonal Antibodies3▲ 23×2 topics
  28. Drug Development Costs3▲ 124×1 topic
  29. Generic Drugs3▲ 124×1 topic
  30. Cost of Care3▲ 160×1 topic
  31. Dendritic Cells3▲ 26×1 topic
  32. Financial Toxicity3▲ 160×1 topic
  33. Tumor Antigen3▲ 37×1 topic
  34. Inappropriate Medication Use2▲ 68×1 topic
  35. Polypharmacy2▲ 68×1 topic
  36. Glycemic Control2▲ 20×4 topics
  37. Diabetes2▲ 4.9×7 topics
  38. Fc Receptors2▲ 25×1 topic
  39. Therapeutic Antibodies2▲ 20×1 topic
  40. Insulin Therapy2▲ 21×3 topics

Which research topics does Five Prime Therapeutics (United States) publish most on?

By volume in 2022–2025: Pharmaceutical Practices and Patient Outcomes, Economic and Financial Impacts of Cancer, Medication Adherence and Compliance and Pharmaceutical Economics and Policy.

  1. 1 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 2 works
  2. 2 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  3. 3 Medication Adherence and Compliance Family Practice 1 works
  4. 4 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
  5. 5 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 0 works
  6. 6 Nematode management and characterization studies Plant Science 0 works
  7. 7 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Cardiac, Anesthesia and Surgical Outcomes Cardiology and Cardiovascular Medicine 0 works
  9. 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  10. 10 Bariatric Surgery and Outcomes Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.9%not open50.1%

World: 28% of research is openly available.

with international co-authors10.5%domestic only89.5%

World: 19% is written across borders.

How has Five Prime Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 25% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in South San Francisco

All research institutions in South San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.